C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
AFCG Equity

Advanced Flower Capital

NASDAQ · AFCG

$2.78
+0.72%
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
55/100 composite
Fundamentals74
Regulatory56
Market40
Editorial30
Composite · trailing 12 months

Advanced Flower Capital (formerly AFC Gamma) lands at 55 on the CIN composite, a Neutral outcome with conviction of 2/5. Fundamentals carry 35 percent of the model, regulatory posture 25, market signal 25, and editorial density 15, with every pillar contribution auditable. Fundamentals leads the pillar table at 74, and is the main lever behind the Neutral conclusion. The offset comes from editorial at 30, which pulls the composite toward the middle of the band.

The observable inputs tell a straightforward story: reported revenue growth of 10.1 percent year over year, an operating margin of 61.0 percent, a market cap near 65 million, a filing cadence of 2 regulator events in the trailing 90 days. Every figure is auditable in the accompanying pillar table. All inputs are drawn from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage density. Because every ticker in the CIN universe is scored on the same 336-name basis, Advanced Flower Capital (formerly AFC Gamma) slots into a direct comparison rather than a bespoke narrative, and the score refreshes on the primary-source ingest cadence.

The next quarterly release stands as the primary catalyst, since fundamentals drive 74 of the composite. A revenue print above the trailing four-quarter average combined with a stable operating margin would justify a step toward the upper band edge, while a miss on either would erode the Neutral anchor.

Scored: 2026-07-14Valid through: 2026-08-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Headquarters
477 S. ROSEMARY AVE., SUITE 301, WEST PALM BEACH, FL, 33401
Phone
561.510.2390
SEC CIK
1822523
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$65.5M
Enterprise value
$157.2M
Price to book
0.36
Price to sales
24.09
Revenue (TTM)
$2.7M
Gross profit (TTM)
$2.7M
Operating margin
61.0%
Profit margin
0.0%
Rev growth YoY
10.1%
Return on equity
-6.9%
Return on assets
-3.7%
EPS (TTM)
$-0.64
EPS est. current year
$1.14
Wall St. target price
$8.00
Dividend per share
$0.35
Dividend yield
11.99%
Shares outstanding
22.8M
Insider ownership
38.3%
Institutional ownership
18.3%
Beta
0.95
GICS sector
Financial Services
GICS industry
Asset Management
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Advanced Flower Capital (AFCG)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Advanced Flower Capital (AFCG), a cannabis-sector equity listed on NASDAQ. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

Analyst average price target $8.0.

CIN editorial stance: Event-Driven Opportunity. Setup improving. Analyst upside 188% detected. (3 bullish signals, 1 bearish signal.)

Bullish and bearish analyst opinions for Advanced Flower Capital (AFCG)

Bullish view. Advanced Flower Capital (formerly AFC Gamma) is a cannabis-focused commercial mortgage REIT with senior-secured lending relationships across US MSOs; bulls model book-value stability and a well-covered dividend supported by senior positions in the operator capital stack.

Bearish view. Bears cite borrower concentration risk, credit-quality sensitivity if MSO balance sheets weaken, and the peer-lender competitive environment which has narrowed spreads as new capital entered cannabis credit.

Live ratings, price targets, and consensus figures for Advanced Flower Capital appear above this summary. Explore analyst coverage across the 326-equity cannabis universe.

Latest price: $2.78 (+0.72%) on NASDAQ.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for AFCG are maintained by Cannabis Investor News and refreshed throughout the trading day.